Hvis lægemidlet uforvarende anvendes under graviditet, eller hvis patienten bliver gravid, mens lægemidlet indtages, bør vedkommende oplyses om den mulige fare for fosteret.
If this medicinal product is used inadvertently during pregnancy, or if the patient becomes pregnant while taking this medicinal product, the patient should be informed of the potential hazard to the foetus.